Option chain shows key data for Vaccinex's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Vaccinex.

Vaccinex (OTC:VCNX) Stock, Option Chain

Vaccinex

Overview

News

Earnings

Insider Trades

Short Interest

Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.

Comments

Vaccinex Option Chain

No option chain data available. Please try again later